BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 169 filers reported holding BRIDGEBIO PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $8,290 | +335.2% | 500,000 | +100.0% | 0.49% | +365.1% |
| Q4 2022 | $1,905 | -99.9% | 250,000 | 0.0% | 0.11% | 0.0% |
| Q3 2022 | $2,485,000 | +9.5% | 250,000 | 0.0% | 0.11% | -12.4% |
| Q2 2022 | $2,270,000 | -10.6% | 250,000 | 0.0% | 0.12% | +14.2% |
| Q1 2022 | $2,538,000 | -39.1% | 250,000 | 0.0% | 0.11% | -6.2% |
| Q4 2021 | $4,170,000 | -64.4% | 250,000 | 0.0% | 0.11% | -56.9% |
| Q3 2021 | $11,718,000 | -30.1% | 250,000 | -9.1% | 0.26% | -22.9% |
| Q2 2021 | $16,764,000 | +8.9% | 275,000 | +10.0% | 0.34% | +25.0% |
| Q1 2021 | $15,400,000 | -27.8% | 250,000 | -16.7% | 0.27% | -40.6% |
| Q4 2020 | $21,333,000 | +42.1% | 300,000 | -25.0% | 0.46% | +25.8% |
| Q3 2020 | $15,008,000 | -23.3% | 400,000 | -33.3% | 0.36% | -33.5% |
| Q2 2020 | $19,566,000 | +22.7% | 600,000 | +9.1% | 0.55% | -18.8% |
| Q1 2020 | $15,950,000 | +127.5% | 550,000 | +175.0% | 0.67% | +148.7% |
| Q4 2019 | $7,010,000 | +63.3% | 200,000 | 0.0% | 0.27% | +57.6% |
| Q3 2019 | $4,294,000 | -20.4% | 200,000 | 0.0% | 0.17% | -21.1% |
| Q2 2019 | $5,394,000 | – | 200,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $55,099,000 | 39.31% |
| M28 Capital Management LP | 466,200 | $4,233,000 | 4.74% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $282,034,000 | 3.75% |
| Octagon Capital Advisors LP | 933,743 | $8,478,000 | 2.26% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $241,719,000 | 1.11% |
| HHLR ADVISORS, LTD. | 5,362,014 | $48,687,000 | 1.04% |
| Cormorant Asset Management, LP | 1,469,179 | $13,340,000 | 1.01% |
| Knott David M Jr | 213,206 | $1,936,000 | 0.81% |
| Fernwood Investment Management, LLC | 183,900 | $1,670,000 | 0.72% |
| HighVista Strategies LLC | 105,942 | $962,000 | 0.58% |